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Treating Chronic Post Herpetic Neuralgia Using
Topical Superconcentrated Capsaicin
Jaree Naqvi1, Scott Seider1, Jason Miller1, Cole Budinsky1, and Amol Soin2 MD, MBA
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Post Herpetic Neuralgia (PHN) is a
painful condition that occurs after
reactivation of the dormant Herpes
Zoster Virus.
Typically PHN presents with a
unilateral rash affecting a single
dermatome which is accompanied
by burning, irritation, and
hypersensitivity for >3 months.
Current treatment includes
anticonvulsants, tricyclic
antidepressants, narcotic/nonnarcotic painkillers, and topical
lidocaine.

Capsaicin is commonly known as
the active chemical in peppers
which is responsible for their
spiciness and the pain and irritation
associated with ingesting them.

The mechanism of action of
capsaicin is believed to be release
of neurotransmitters upon binding
to capsaicin nociceptors, mainly
TRPV1.

Boonshoft School of Medicine, Dayton, OH
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The Ohio Pain Clinic, Dayton, OH

Twenty patients suffering from
severe chronic pain from PHN were
identified and recruited for the trial.

Patients were followed up at 2
week and 1 month intervals.

Our protocol included applying
Eutectic Mixture of Local
Anesthetic (EMLA) to the affected
dermatome for 1 hour prior to
Qutenza application to prevent
capsaicin-associated pain and
irritation.

¾ 3 patients reported no relief

¾ 16/20 patients reported relief

¾ 1 patient reported worsening
pain

Figure 2. Outline affected area

Figure 3. Application of EMLA

Following EMLA administration,
the Qutenza patch was applied
over the affected dermatome.

The sixteen responders collectively
reported a 53.2% decrease in
frequency and severity of pain,
assessed using qualitative scales.

The treatment protocol using
Qutenza to treat refractory PHN
proposes a novel approach to the
treatment of this condition.
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Once the neuron is damaged or
depleted of neurotransmitters, pain
perception is notably diminished
for a period of time thereby
effectively providing relief.

Qutenza was applied until the pain
became unbearable. Vital signs +
pain score were reassessed every
15 minutes while the patch was on.
At the conclusion of cases, the
patch was removed and a
cleansing gel was applied to
decrease irritation and pain.

We believe that our treatment algorithm is an
effective method for controlling the pain
associated with PHN, and the relief
associated with the treatment outweighs the
pain associated with undergoing the
procedure.
However, more data is needed to provide
statistically significant data and we will
continue to gather subjects and analyze
results to determine the true effectiveness of
this therapy.
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Figure 1. Effects of Qutenza Patch

Given that treatment can be given every 3
months while patients report a relapse in
pain within 6 months on average,
theoretically Qutenza application could be an
effective lifelong treatment, or until pain
subsides on its own.
These results show that the proposed
treatment protocol for Qutenza is effective
using our initial snapshot of twenty patients.
Continued patient recruitment and follow-up
is planned to collect more data.

At large doses, capsaicin causes
depletion of neurotransmitters and
can ultimately lead to nerve fiber
denervation

We propose the utilization of a
superconcentrated transdermal
patch of capsaicin called Qutenza
8%, which is 300 times more potent
than current OTC capsaicin.

The Qutenza treatment showed an average
of a 53.2% reduction in pain, as was expected
with this treatment.

Figure 4. Qualitative pain scale

Patients reported an average relief
time of 4.2 months with Qutenza
therapy, with full pain sensation
returning within 6 months following
treatment. Patients are eligible for
repeat treatment every 3 months.

